MedTrace Logo

Oral vs Rectal Admin of Naproxen for Post-Vag Perineal Pain Control

NCT00222976 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2007-11-15

No results posted yet for this study

Summary

The primary objective of this study is to determine whether the route of administration of naproxen (either by mouth or rectally) influences post-vaginal delivery perineal pain control.

Conditions

  • Post-Vaginal Delivery Perineal Pain

Interventions

DRUG

Naproxen

Treatment allocation either A Naproxen PO + placebo PR or B Placebo PO + Naproxen PR

Sponsors & Collaborators

  • Saskatoon Health Region

    collaborator OTHER

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • David C Campbell, MD,MSC,FRCPC · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Completion
2007-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00222976 on ClinicalTrials.gov